Explore a little further

oncology

Stories and perspectives from Daytrade News.

From Daytrade News

8 stories shown · Newest added
Daytrade News

Iambic Therapeutics Surges 16% in Nasdaq Debut Following $150M IPO

Iambic Therapeutics, an AI-driven biotech firm, experienced a strong market debut on Nasdaq, with shares rising 16% to $18.50 after a $150 million IPO. The company aims to innovate cancer treatment through its proprietary AI systems and has significant backing from notable inves…

More perspectives

Across our publications

A selection of related stories